规格: | 98% |
分子量: | 640.8 |
包装 | 价格(元) |
500ug | 电议 |
1mg | 电议 |
Background:
Dabigatran etexilate-d13is intended for use as an internal standard for the quantification of dabigatran etexilate by GC- or LC-MS. Dabigatran etexilate is a double prodrug that undergoesin vivohydrolytic cleavage to produce dabigatran , a potent thrombin inhibitor (Ki= 4.5 nM).1,2Dabigatran etexilate shows antithrombotic efficacy in animal models of thrombosis, with a rapid onset of action.2It is not metabolized by cytochrome P450 isozymes and has a low potential for drug-drug interactions.
1.Hauel, N.H., Nar, H., Priepke, H., et al.Structure-based design of novel potent nonpeptide thrombin inhibitorsJ. Med. Chem.45(9)1757-1766(2002) 2.Eisert, W.G., Hauel, N., Stangier, J., et al.Dabigatran: An oral novel potent reversible nonpeptide inhibitor of thrombinArterioscler. Thromb. Vasc. Biol.30(10)1885-1889(2010)